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a  b  s  t  r  a  c  t
Objective:  To  review  current  knowledge  regarding  the  prevalence  of  somatization  problems  in later  life
by level  of  caseness  (somatoform  disorders  and  medically  unexplained  symptoms,  MUS)  and  to  compare
these rates  with  those  in  middle-aged  and  younger  age  groups.
Method:  A  systematic  search  of the  literature  published  from  1966  onwards  was  conducted  in  the  Pubmed
and EMBASE  databases.
Results: Overall  8 articles,  describing  a total  of  7 cohorts,  provided  data  of  at least  one  prevalence  rate
for  somatoform  disorders  or MUS  for  the  middle-aged  (50–65  years)  or older  age  (≥65  years)  group.
Prevalence  rates  for somatoform  disorders  in the general  population  range  from  11  to  21%  in  younger,  10
to  20%  in  the  middle-aged,  and  1.5 to 13%  in  the  older  age  groups.  Prevalence  rates  for MUS  show  widerpidemiology ranges,  of  respectively  1.6–70%,  2.4–87%,  and  4.6–18%,  in the  younger,  middle,  and  older  age  groups,
which  could  be  explained  by  the  use of  different  instruments  as well  as  lack  of consensus  in  deﬁning
MUS.
Conclusion:  Somatoform  disorders  and  MUS  are  common  in later  life, although  the  available  data  suggest
that prevalence  rates  decline  after  the  age  of 65  years.  More  systematic  research  with  special  focus  on
the  older  population  is  needed  to  understand  this  age-related  decline  in  prevalence  rates.. Introduction
Medically unexplained symptoms (MUS) are physical symp-
oms of which presence, severity or consequences cannot be
onclusively explained by any detectable physical disorder
Lipowski, 1988). MUS  are common in the general population with
eported prevalence rates in primary care varying between 25 and
0% (Burton, 2003; Escobar et al., 2010; olde Hartman et al., 2009).
ithin the International Classiﬁcation of Diseases version 10 (ICD-
0) as well as the Diagnostic and Statistical Manual for Mental
isorders version IV (DSM-IV), medically unexplained symptoms
re classiﬁed under the section of somatoform disorders. In order
o meet the ofﬁcial criteria for any of these somatoform disorders,
he ICD-10 places emphasis on ‘a psychological cause’ of bodily
ymptoms, whereas in the DSM-IV for most somatoform disorders a
sychological cause has to be assumed and most emphasis is placed
n the presence of signiﬁcant impairment in social, occupational
nd/or other areas of functioning due to MUS. Reported prevalence
∗ Corresponding author at: Pro Persona, PO Box 7049, 6503 GM Nijmegen, The
etherlands. Tel.: +31 24 3283456; fax: +31 24 3283606.
E-mail address: p.hilderink@propersona.nl (P.H. Hilderink).
568-1637/$ – see front matter ©  2012 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.arr.2012.04.004© 2012 Elsevier B.V. All rights reserved.
rates for all forms of somatoform disorders together vary from 10
to 25% in primary care (de Waal et al., 2004; Dekker et al., 2008;
Faravelli et al., 1997; Roca et al., 2009; Steinbrecher et al., 2011).
Whether somatization, the tendency to express psychological dis-
tress with somatic complaints, is more common in old age remains
a matter of debate (Creed and Barsky, 2004; Schneider and Heuft,
2011; Sheehan and Banerjee, 1999).
Patients with MUS  or somatoform disorder report signiﬁ-
cant decreases in quality of life, impairment in daily functioning,
increased high health care utilization, and often undergo medical
examinations and treatments unnecessarily (Barsky et al., 2005;
Koch et al., 2007; Margalit and El-Ad, 2008). In an adult population,
MUS  double the costs for both inpatient and outpatient health care
utilization compared to patients without MUS  when adjusted for
the presence of comorbid psychiatric and somatic disease (Barsky
et al., 2005). Moreover, the increase of health care utilization over
a follow-up period of 5 years was higher in MUS  patients than
in patients without MUS  (Barsky et al., 2005). Furthermore, this
increase was  higher than the increase associated with depressive
disorder or anxiety disorders, disorders that are also associated
with increased health care consumption over time (Grabe et al.,
2009). Increased medical consumption is not only problematic from
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amage due to unnecessary additional diagnostic and treatment
rocedures or signiﬁcant doctor’s delay (by not taking patients
eriously anymore). These risks are probably even more relevant
n later life, as older persons are frailer, have a higher a priori
hance of underlying somatic diseases, and are more dependent on
arers.
The past decades, several psychiatric interventions for MUS  and
omatoform disorders have been proven effective (Sumathipala,
007). This optimism is tempered by the experience that numer-
us patients with MUS  refuse “psychological treatment” (Martens
t al., 2010). Older people may  be at double risk for withdrawal
f adequate treatment. First, older people are less often offered
sychological therapy (Cooper et al., 2010). Nevertheless, age does
ot seem to be a factor associated with the acceptance of psycho-
ogical treatment for functional symptoms (Martens et al., 2010).
econdly, in case of older patients, physicians are often faced with
omatization in the context of chronic somatic diseases. Higher
omorbidity rates as well as higher a priori chances of under-
ying physical illnesses as explanation for MUS  in older people
ay  caution physicians to diagnose MUS  or a somatoform dis-
rder (Nimnuan et al., 2000). Therefore, data showing increased
umbers of somatic explained symptoms with increasing age and
o or only a very weak correlation between MUS  and age are
ifﬁcult to interpret (Clarke et al., 2008; Kingma et al., 2009;
ittle et al., 2001). For example, frequent attenders, often used
s a proxy for MUS, are more common among older persons
han younger persons (Ladwig et al., 2010), but when corrected
or all other signiﬁcant factors, such as number of chronic dis-
ases, age itself was not associated with frequent attending (Little
t al., 2001). Furthermore, prevalence studies in Dutch primary
are have yielded inconsistent ﬁndings for older patients, show-
ng lower rates for somatoform disorders, but increased prevalence
ates for persistent MUS  (de Waal et al., 2004; Verhaak et al.,
006).
To our knowledge, only two reviews have published on somato-
orm disorders in the elderly speciﬁcally (Sheehan and Banerjee,
999; Schneider and Heuft, 2011). The review by Sheehan and
anerjee (1999) was conducted before the majority of epidemi-
logical studies on the prevalence of somatoform disorder in later
ife have been published. Nevertheless, these authors concluded
hat somatization disorder in itself is rare in the older popula-
ion, but that clinically relevant somatization occurs frequently.
lthough the authors warn to use “masked depression” as explana-
ion for somatization in older persons, they acknowledge the high
omorbidity between somatoform and mood disorders. The impor-
ance to disentangle somatization from pure anxiety or depression
s substantiated by another review, not speciﬁcally focussed on
lder persons. It shows that having numerous somatic symptoms or
llness worry is associated with impairment and health care utiliza-
ion independent of anxiety and depressive symptoms (Creed and
arsky, 2004). A German, more recent and systematic review on the
ffect of aging on somatization stated that ageing per se is not asso-
iated with an increased level of somatization, but that the scarcity
f empirical data preclude ﬁnal conclusions (Schneider and Heuft,
011). Both reviews identiﬁed problems caused by between-study
ifferences in the deﬁnition of somatization problems, instruments
sed to measure somatization, and ﬁnally the setting of the research
opulation.
The objective of the present study is to estimate the prevalence
f somatization problems in the older population. More speciﬁcally,
e will ﬁrst estimate prevalence rates according to the level of
aseness, i.e. MUS  and somatoform disorders according to DSM or
CD criteria. Secondly, we will compare prevalence rates of MUS  and
omatoform disorders in older age groups (≥65 years) with those
ound in middle aged (50–65 years) and younger populations (<50
ears).h Reviews 12 (2013) 151– 156
2. Methods
We  performed systematic searches of the PubMed and EMBASE
databases for the period 1966 through June 2011 using the key-
words: medically unexplained symptoms, somatoform disorder,
aged, prevalence, epidemiology. If applicable to the keyword, MeSH
terms were included and then combined with the search.
We  used the following criteria for inclusion of articles:
• Firstly, articles had to provide prevalence rates of somatoform
disorders or MUS. Acknowledging the scarcity of empirical data,
we  did not apply a time-reference to the prevalence rate, but we
will report the time-reference of the included studies systemati-
cally.
• Secondly, prevalence rates had to be described for different age
categories, including at least one age group above 50 years of
age. We  deﬁned older persons as those aged 65 years or older,
as in most developed countries the chronological age 65 years
coincides with retirement and is generally accepted as a cut-off
for deﬁning the elderly (Roebuck, 1979). Acknowledging that this
deﬁnition of old age is somewhat arbitrary, we also deﬁned a
middle-aged group consisting of persons aged 50–65 years as this
is a period in which many chronic physical conditions start to
develop.
• Thirdly, somatoform disorders had to be classiﬁed according DSM
criteria and/or ICD criteria using standardized instruments. MUS
are deﬁned as physical symptoms of which presence, severity
or consequences cannot be explained by any detectable phys-
ical disorder. Acknowledging the lack of consensus for deﬁning
MUS, we  did not apply speciﬁc restrictions with respect to deﬁni-
tion or classiﬁcation if methods were described in a reproducible
manner.
• Fourthly, the study had to be conducted in the general population
and/or primary care setting.
We  did not apply any restrictions on the language of the article.
We performed two  searches in Pubmed to identify articles about
somatoform disorders and MUS, respectively. Using the keywords:
medically unexplained symptoms, aged, prevalence yielded 116
hits. A second search using the keywords: somatoform disorder,
aged, prevalence and epidemiology yielded 117 hits. Screening of
all titles resulted in further examination of 38 abstracts and 35 full
text articles, from which ﬁnally only six articles met  our inclusion
criteria. References were checked and provided two  more useful
articles. Repeating our search strategy in EMBASE did not yield
any additional articles. Searches were performed independently by
both PH and RC, where after results were compared and discussed.
In case of disagreement RCOV was  consulted for a ﬁnal decision.
2.1. Statistical methods
Although we  originally intended to perform formal meta-
analyses, we  deemed a descriptive overview of the data more
appropriate for the following reasons. Firstly, the number of arti-
cles was small. Secondly, results were heterogeneous, also after
differentiating between somatoform disorders and MUS.
3. Results
Overall eight articles, describing a total of seven cohorts, were
found that met  our criteria (see Table 1). In four of these seven
cohorts somatoform disorders as well as MUS  were assessed. The
prevalence data of somatoform disorders and MUS  in one cohort
have been described in separate articles (Fröhlich et al., 2006; Jacobi
et al., 2004). The three other cohorts only focussed on somatoform
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Table 1
Summary of prevalence rates (%) for somatoform disorders and MUS  by age.
Study Setting Number Diagnostic instrument Age-group
Name Time-window <50 years >50–65 years >65 years
Somatoform disorders
Hardy 1995 General population N = 504 Telephonic
interview
12 months 21 20 13
Jacobi  2004 General population N = 1321 CIDI 12 months 10.7 11.7
Leiknes 2007 General population N = 1247 CIDI 6 months 11.4 (m:7.3; v:15.1) 9.9 (m:3.8; v:16.4) 4.9 (m:3.5; v:6.5)
Hiller  2006a General population N = 2552 SOMS-7 7 days 12.6 26.8b
Waal de 2004a Primary care
Primary care
N = 1046 SCAN 6 months 21.8 15.3 5.4
Lyness  1999 N = 224 SCID Point prevalence 1.5 (m:1.3; v:1.6)
Medically unexplained symptoms
Frohlich 2005 General population N = 1321 CIDI 12 months 28.8 (m:22.9; v:34.8) 27.2 (m:21.3; v:33.1)
Leiknes  2007 General population N = 1247 CIDI 6 months 26.3 (m:17.0; v: 34.8) 23.4 (m:15.3; v:32.2) 18.4 (m:16.3; v:20.8)
Hiller  2006a General population N = 2552 SOMS-7 7 days 69.7 87.1b
Waal de 2004a Primary care N = 1046 SCAN 6 months 27.8 22.4 7.2
Verhaak 2006a Primary care N = 225,013 Persistent
MUSc
12 months 1.6 2.4 4.6


































sa Age cut-off for the younger age group was set at 45 years.
b This prevalence rate provides all persons of the age of 45 years or above (range
c Persistent MUS  were deﬁned as: at least four contacts with a functional sympto
isorders (Hardy, 1995; Lyness et al., 1999) or on MUS (Verhaak
t al., 2006), respectively.
.1. Age groups
Four studies provided prevalence data for persons aged 65 years
r above (de Waal et al., 2004; Hardy, 1995; Leiknes et al., 2007;
erhaak et al., 2006), with one study applying an age cut-off at
0 years (Lyness et al., 1999). The age cut-off for the middle-aged
ersons was even less consistent, with three studies using a cut-off
t 45 years (de Waal et al., 2004; Hiller et al., 2006; Verhaak et al.,
006) and four studies at 50 years (Hardy, 1995; Fröhlich et al.,
006; Jacobi et al., 2004; Leiknes et al., 2007). Nevertheless, two
f these former studies (de Waal et al., 2004; Verhaak et al., 2006)
lso reported prevalence data for those aged above 65 years or age
and were thus of interest). The other study (Hiller et al., 2006) only
sed the cut-off of 45 years did not provide further differentiation
egarding the higher age group.
.2. Populations
We found four population surveys conducted in three different
ountries: two papers described data from the same German sam-
le (German Health Survey (GHS), n = 1321), one about somatoform
isorders and one about MUS  (Fröhlich et al., 2006; Jacobi et al.,
004); another paper also described a German sample (n = 2552)
Hiller et al., 2006), one paper described a Norwegian sample
n = 1247) (Leiknes et al., 2007) and ﬁnally the last described a
rench sample (n = 504) (Hardy, 1995).
Three other studies, two from the Netherlands (de Waal et al.,
004; Verhaak et al., 2006) (n = 1046 and n = 225013, respectively)
nd one American study (Lyness et al., 1999) (n = 224), described
revalence rates in primary care.
.3. Used instruments
None of the studies included in the review used a similar diag-
ostic procedure. The most important differences were (1) whether
r not a screening procedure was used, (2) type of diagnostic instru-
ent that was used, and (3) the time-window that was applied.
Five of the studies used a two-stage screening procedure. Four
tudies started with a screening questionnaire and if positive, years).
 without a medical diagnosis as an explanation for the symptoms during 1 year.
performed a diagnostic interview for somatoform disorders (de
Waal et al., 2004; Fröhlich et al., 2006; Jacobi et al., 2004; Leiknes
et al., 2007). The study of Lyness used the Center of Epidemiologic
Studies Depression Scale (CES-D) as screening (Lyness et al., 1999).
All persons above the cut-off point of 21 were included and a
random sample of persons scoring under the cut-off point, aiming
to oversample the amount of depressive disorders. The diagnostic
instruments that have been used varied from fully structured
interviews (Fröhlich et al., 2006; Jacobi et al., 2004; Leiknes et al.,
2007; Lyness et al., 1999), to a semi-structured interview (de Waal
et al., 2004) to a self-report questionnaire (Hiller et al., 2006), to
chart-review (Verhaak et al., 2006) and ﬁnally to a telephonic inter-
view (Hardy, 1995). Even the two  studies that used the somatoform
section of the fully structured computerized Composite Interna-
tional Diagnostic Interview (CIDI) were not fully comparable by
taking a different time-windows describing respectively 12-month
(Fröhlich et al., 2006; Jacobi et al., 2004) and 6-month prevalence
rates (Leiknes et al., 2007). One study assessed current somatoform
disorders with a duration of at least 6 months by using the semi-
structured Schedules for Clinical Assessment in Neuropsychiatry
(SCAN) (de Waal et al., 2004). The SCAN leaves room for further
exploration and clinical judgement by experienced mental health
professionals and is often considered the gold standard for diag-
nosing psychiatric disorders. Another study used the Screening for
Somatoform Symptoms (SOMS-7), a standardized questionnaire
that asks for symptoms in the last seven days (Hiller et al., 2006).
One study used a two stage telephonic interview based on the
classiﬁcation according to DSM-IV to identify somatoform disor-
ders in the last year (Hardy, 1995). Finally, the last study used data
extracted from electronic records of 225,013 patients of 104 gen-
eral practices based on the International Classiﬁcation of Primary
Care (ICPC). This study focussed on chronic MUS, deﬁned as four or
more contacts for a somatic complaint, without a medical diagnosis
in the period of a year. They argued that this deﬁnition is most close
to clinically relevant somatoform problems (Verhaak et al., 2006).
3.4. Prevalence ratesTable 1 shows prevalence rates for different age categories for
somatoform disorders in the included articles. Given prevalence
rates are for all different forms of somatoform disorders together.
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1% in the younger age group (below 45–50 years), 10 through 20%
n the middle-aged group (45–50 to 60–65 years), and from 1.5
hrough 13% in the older age group (60–65 years or above). None of
he studies found any differences between the younger and middle
ge groups, whereas the prevalence rate in the older age groups
ere consistently lower. Only one study found increasing preva-
ence rates above the age of 45 years, but this study did not report
revalence rates for persons aged 45–65 years and persons aged
ver 65 years separately (Hiller et al., 2006).
Reported prevalence rates for MUS  are even more heteroge-
eous with highest prevalence rates for MUS  deﬁned as at least
ne symptom of mild severity in the past seven days (Hiller et al.,
006) and lowest prevalence rates for chronic persistent MUS  in
rimary care (Verhaak et al., 2006). Interestingly, the study repor-
ing persistent MUS  in primary care found increasing prevalence
ates with age, i.e. 1.6% below the age of 45 years, 2.4% for the age
roup between 45 and 65 years and ﬁnally 4.6% for those aged 65
r above (Verhaak et al., 2006). The age-effects in the other three
tudies were in line with those reported for somatoform disorders,
.e. no difference in prevalence rates between the age groups below
0 years and between 50 and 65 years, but clearly lower prevalence
ates in the age group above 65 years (de Waal et al., 2004; Fröhlich
t al., 2006; Leiknes et al., 2007).
. Discussion
Acknowledging the scarce literature on somatoform disorders
nd MUS  in later life, our data suggest that somatoform disorders
nd MUS  are common in older populations, although prevalence
ates are lower than in younger populations. The differences
etween studies can partly be explained by the use of different diag-
ostic instruments, whereas the applied time-window may  be less
mportant. It seems plausible that semi-structured interview meth-
ds are more restrictive and therefore ﬁnd lower prevalence rates
han questionnaires (Schneider and Heuft, 2011). For example, all
emi-structured interviews take only symptoms into account that
ave led to health care utilization. Looking at the population sur-
eys we included, we indeed found the highest prevalence rates in
he study that used a questionnaire (Hiller et al., 2006). The lowest
revalence rate of 1.5%, found among American older patients in
rimary care by using the Structured Clinical Interview for DSM-IV
isorders (SCID) in a sample with relative oversampling of depres-
ive persons, may  seem puzzling (Lyness et al., 1999). The most
ikely explanation is that the authors only reported prevalence rates
or pain disorder and body dysmorphic disorder, whereas the more
revalent somatoform disorders like undifferentiated somatoform
isorder and hypochondria were not assessed. A second, but less
ikely explanation is the inclusion in this study of patients from
rivate internal medicine practices, as these patients might have
ad higher socio-economic backgrounds.
Although only four of the included studies did report prevalence
ates for the age group above 65 years, the results suggest that
revalence rates of somatoform disorders and MUS are stable until
he age of 65 years and decrease thereafter. The only exception
o this ﬁnding is the study concerning persistent MUS, showing
ncreased prevalence rates above the age of 65 years (Verhaak
t al., 2006). These ﬁndings are in line with studies of somatoform
isorders in highly selective samples (that had to be excluded for
he present review for this reason (Balestrieri et al., 2005; Heun and
ein, 2005; Lish et al., 1995)). Using the SCREENER questionnaire
o screen for psychiatric disorders in a medical outpatient clinic
opulation, 18% of the patients below the age of 63 years had a
omatoform disorder versus 11% of those aged above 63 years (Lish
t al., 1995). A study among a later life subpopulation (above the
ge of 55 years) of families of patients with Alzheimer’s dementiah Reviews 12 (2013) 151– 156
or depression yielded a prevalence rate of 5% for somatoform
disorder as assessed by the CIDI (Heun and Hein, 2005). This is
similar to later life prevalence rates in included studies that used
the CIDI as diagnostic instrument that found a prevalence rate of
5% above 65 years of age (Leiknes et al., 2007). Nevertheless, also
some lower than expected ﬁgures have been reported. Among
long-term older benzodiazepine users who  visited their general
practitioner, a prevalence rate of 8% for somatoform disorders
was found using the PRIME-MD questionnaire (Balestrieri et al.,
2005). This seems in line with other reported ﬁndings, although
among benzodiazepine users the expected prevalence rate would
be higher (Mol  et al., 2005).
Nevertheless, two  studies included in the review reported
increasing prevalence rates for somatoform disorders and MUS
with increasing age. Both studies, however, might be biased by the
limited ability to separate medically explained and unexplained
symptoms, leading to an overrepresentation of somatoform com-
plaints of which an organic cause is not excluded (Schneider and
Heuft, 2011). The ﬁrst study, only differentiating between patients
under and above 45 years of age, used a self-report questionnaire
(SOMS-7) assessing all 53 physical symptoms reported in the DSM-
IV criteria for somatoform disorders (Hiller et al., 2006). Recently,
we showed that in older persons the Patient Health Questionnaire
(PHQ-15), a screenings instrument used to establish symptoms
that point to somatoform disorders, had a similar correlation with
an index of hypochondriasis (Whiteley Index) as an index of the
burden of underlying chronic somatic diseases (Cumulative Illness
Rating Scale) (Benraad et al., submitted for publication). This means
the physical symptoms assessed by the DSM-IV might be less spe-
ciﬁc for somatoform disorders in older people, than in younger
people. The second study used a very speciﬁc deﬁnition, which
included a minimum of four visits a year at the GP for a somatoform
complaint. This deﬁnition may  have led to biased results, as older
persons with somatoform complaints tend to be more frequent
attenders than younger adults (Ladwig et al., 2010)
4.1. Why  do prevalence rates for somatoform disorders and MUS
decrease in the elderly?
Current classiﬁcation systems for somatoform disorders are not
deemed appropriate for clinical use (Escobar et al., 1998; Kroenke
et al., 1997). The formal criteria for a somatization disorder are
quite restrictive. These criteria may  be especially restrictive for
elderly (Escobar et al., 2010; Wijeratne et al., 2003). For example,
the inclusion criterion for somatization disorder is a presence of
symptoms before onset of 30 years. Poor patient recall will bias
and lower rates (Robins et al., 1984; Simon and Gureje, 1999). Over-
all prevalence rates of somatoform disorders may thus be lowered
artiﬁcially, further substantiated by much higher prevalence rates
for suggested abridged forms of somatization disorder (Creed and
Barsky, 2004).
Secondly, used interview methods are not validated for an
elderly population, which may  lead to lower estimated preva-
lence rates for somatoform disorders. Epidemiological studies
using standardized diagnostic interviews for other mental disor-
ders, especially depression, have consistently demonstrated lower
current and lifetime prevalence estimates in later life populations
compared to younger populations (Anon., 1992; Regier et al., 1984).
Analyses of epidemiologic data in a population from 25 to 64 years
based on the Diagnostic Interview Schedule (DIS) showed that older
people more often attributed their symptoms to a physical condi-
tion in probe questions designed to identify the degree to which
symptoms were caused by factors other than psychological. It was
suggested that this response was  due to the fact that the complex-
ity of the formalized questions exceeded the cognitive capacity.
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his response behavior, also when corrected for co-morbid physical
onditions (Knäuper and Wittchen, 1994). Because working mem-
ry capacity decreases with on-going age (Palladino and De Beni,
999), this effect might become more prominent among older per-
ons. The attribution of symptoms to a physical condition will lead
o exclusion of diagnosis of somatoform disorder and thus to lower
stablished prevalence rates for somatoform disorders. Thirdly,
ot only do older patients attribute bodily symptoms to physical
isorders, older persons also have more co-morbid somatic disor-
ers, which makes doctors reluctant to exclude a somatic origin
f the complaint. We  previously have reported that 50% of patients
eferred to our outpatient clinic for MUS  had a somatic disorder that
artly explained their symptoms (Hilderink et al., 2009). Exclud-
ng patients with a partial, but not sufﬁcient somatic origin of
heir symptoms, will lead to substantial lower prevalence rates.
ndeed some studies reported to exclude patients in which there
as any doubt about a somatic cause for the complaint (de Waal
t al., 2004). Because of confusing terminology for somatoform dis-
rders within the DSM-IV with implicit mind-body dualism and
he unreliability of assessments of MUS, the American Psychiatric
ssociation has proposed to rename the chapter of somatoform
isorders into ‘somatic symptom disorders’. The DSM-V Somatic
ymptom Disorder Task Group has proposed to lump somatization
isorder, hypochondriasis, undifferentiated somatoform disorder
nd pain disorder together in one disorder named Complex Somatic
ymptom Disorder (Dimsdale et al., 2009). This is in line with
mpirical ﬁndings showing that the number of medically explained
nd unexplained symptoms are more informative for a dimensional
iagnosis of somatization than the clustering of speciﬁc symp-
oms into separate somatoform disorders or functional syndromes
Nimnuan et al., 2001; olde Hartman et al., 2004; Rosmalen et al.,
010). As the DSM-V will focus more on the number of bodily symp-
oms, irrespective of explainability or unexplainability of these
ymptoms or their associated dysfunctional cognitions, these new
riteria may  better serve older people. A ﬁnal explanation could be
hat in old age subsyndromal forms of somatoform disorders are
ore common than somatoform disorders meeting full DSM crite-
ia. This could be similar to depressive disorders in later life, where
inor depression is much more common than major depression
Beekman et al., 1995). This latter explanation, however, cannot
ully explain the lower prevalence rates of somatoform disorders in
ater life as MUS, which can be considered a subsyndromal somato-
orm disorder, also decreases with age.
.2. Limitations
For proper interpretation, some limitations should be acknowl-
dged. Firstly, empirical data are scarce. Therefore, we  choose to
pply the cut-off for our a priori chosen age-categories liberally
n order to be able to provide a more detailed overview of the
iterature. Nevertheless, the general neglect of somatoform dis-
rders and MUS  in old age still raises the question whether the
ew studies reported can be considered representative for the
ommunity-dwelling elderly population. Overall prevalence rates
f somatoform disorders and MUS  in the included studies, how-
ver, were in line with the prevalence rates in studies that also
ncluding middle-aged (50–65 years) and/or older persons (aged
65 years) but that did not report age-speciﬁc data. For exam-
le, a German study using the CIDI found an overall prevalence
ate for any somatoform disorder of 11% in the general popula-
ion (n = 4181) aged from 18 to 65 (Dekker et al., 2008). An Italian
tudy of the general population (n = 673) reports a prevalence of
0% for all somatoform disorders using a semi-structured inter-
iew by a trained interviewer (Faravelli et al., 1997) and a Spanish
tudy in primary care (n = 7936) found a prevalence of 29% using
he PRIME-MD questionnaire (Roca et al., 2009).h Reviews 12 (2013) 151– 156 155
Secondly, the use of different instruments for assessing somato-
form disorders limits direct comparison between studies. Although
these limitations are also applicable to the younger population,
research in old age psychiatry is further limited by fact that most
diagnostic instruments for somatoform disorders are not validated
for use in the elderly (Knäuper and Wittchen, 1994). Moreover, no
consensus exist on the deﬁnition of MUS, whereas the criteria for
somatoform disorders remain also highly debated and have led to
widely different solutions within research projects varying from
the introduction of other diagnostic entities such as abridged som-
atization disorder (Escobar, 1997) and multi-somatoform disorder
(Kroenke et al., 1997).
4.3. Conclusion
So far, little research has focused on somatoform disorders in
the elderly. The existing evidence shows that somatoform disor-
ders and MUS  are still common in later life, although the available
data suggest that prevalence rates decline after the age of 65
years. To understand why prevalence rates decrease beyond the
age of 65, more systemic research with special focus on the old
aged population is needed. Especially adaptation and validation
of instruments to detect somatoform disorders in the elderly is
needed for this purpose. To reveal the clinical relevance and natu-
ral course of subsyndromal somatoform disorders, research should
focus on studying diversity, severity and chronicity of MUS  rather
than differentiating into separate diagnostic categories with arbi-
trary thresholds (Rosmalen, 2010). Because of the lack of consensus
on the deﬁnition of MUS, the prevalence rates for somatoform
symptoms that do not fulﬁll the DSM-IV criteria are difﬁcult to
interpret and the clinical importance of subsyndromal somatoform
disorders remains uncertain. Suggestions for future classiﬁcation
should consider the appropriateness for old age populations.
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